Today: 29 April 2026
Nvidia stock price jumps after Amazon flags bigger AI spend — what investors watch next
6 February 2026
1 min read

Nvidia stock price jumps after Amazon flags bigger AI spend — what investors watch next

New York, February 6, 2026, 16:10 (EST) — After-hours

  • Nvidia jumped roughly 8% in U.S. trading, recouping ground alongside other chipmakers.
  • Amazon’s stepped-up AI capital spending plans gave semiconductors a boost.
  • Nvidia faces its next big hurdle with results coming up Feb. 25.

Nvidia (NVDA.O) bounced back in late U.S. trading, climbing $14.20, or roughly 8.3%, to $186.08. Earlier in the week, the stock had stumbled as investors worried about lofty AI-related valuations. Shares ranged wildly, dipping as low as $172.62 before touching $186.93. Chip stocks caught a lift after Amazon flagged plans for heftier data-center spending. “There’s real demand for AI products,” said Baird’s Ross Mayfield, investment strategy analyst. Reuters

Wall Street is grappling with the hefty price tag of AI, even as investment plans balloon. The big tech cohort is eyeing roughly $600 billion in AI spending for 2026, a figure that’s stirring up nerves among investors. Some traders are already paring back exposure to the most heavily trafficked AI names. “It’s not that the trade is over, but it got too pricey,” SanJac Alpha’s chief investment officer Andrew Wells said. Reuters

With Nvidia, it comes down to a single question: how much are the largest cloud players willing to pour into chips and the data center infrastructure behind them? Capex—industry shorthand for long-term outlays on servers, networking equipment and facilities—remains front and center in that calculation.

Amazon is projecting capital expenditures of about $200 billion for 2026, a jump from $131 billion planned for 2025. Shares slipped after hours, with investors reacting to the scale of the spending. “The market just dislikes the substantial amount of money that keeps getting put into capex,” said Dave Wagner, a portfolio manager at Aptus Capital Advisors. Reuters

Alphabet plans to ramp up capital expenditures to between $175 billion and $185 billion in 2026, a sharp jump from the $91.45 billion targeted for 2025, all in the name of boosting computing power. “We are seeing our AI investments and infrastructure drive revenue and growth across the board,” CEO Sundar Pichai told analysts. Reuters

Supply-chain sentiment held firm. Wistron’s chairman, Simon Lin—his firm supplies Nvidia—dismissed talk of an AI bubble and pointed to order visibility stretching all the way to 2027. CEO Jeff Lin added that the company expects to kick off volume production at its new U.S. sites in the first half of 2026.

Nvidia isn’t out of the woods yet when it comes to policy risk, particularly tied to China. The Trump administration has signaled it would permit ByteDance to purchase Nvidia’s H200 chips, but people familiar say talks are snagged on license terms and Know-Your-Customer hurdles. “For American industry to make any sales, the conditions need to be commercially practical,” an Nvidia spokesperson said. Reuters

The spotlight now turns to Nvidia, whose quarterly results are up next. The company plans to release its fourth-quarter and full-year 2026 numbers on February 25. After the results drop, written remarks from the CFO are expected online before the earnings call.

Stock Market Today

  • Qualcomm Q2 Earnings Preview Amid Smartphone Market Downturn
    April 29, 2026, 1:07 PM EDT. Qualcomm is set to report second-quarter earnings amid a sharp downturn in the global smartphone market. The company, known for its smartphone chips, faces challenges as shipments fell 4.1% in Q1, marking an end to a 10-quarter growth streak. Analyst Ming-Chi Kuo highlights Qualcomm's upcoming AI chip with OpenAI, aiming for mass production in 2028 to challenge Apple and Google's dominance. Despite diversification into data centers and automotive sectors, the handset division, driving most revenue, is expected to drop 12.5% year-over-year. Qualcomm forecasts Q2 revenue of $10.56 billion and earnings per share of $2.55, down from last year. CEO Cristiano Amon's upcoming keynote could shed light on the company's AI and data center strategies amid this challenging market.

Latest article

Teva Stock Jumps As Branded Drugs Start Carrying The Old Generics Giant

Teva Stock Jumps As Branded Drugs Start Carrying The Old Generics Giant

29 April 2026
Tel Aviv, April 29, 2026, 20:03 (IDT) Teva Pharmaceutical Industries’ New York-listed shares rose sharply on Wednesday after the Israel-based drugmaker beat first-quarter profit expectations, helped by a faster shift toward branded medicines and away from lower-margin generics. The move gave investors a clearer test of Chief Executive Richard Francis’s turnaround plan, not just another quarter of cost cuts. The timing matters because Teva’s three key growth drugs — Austedo for movement disorders, Ajovy for migraine and Uzedy for schizophrenia — are now doing more of the work once expected from its generics engine. Teva said the three brands generated
Silicon Motion Stock Jumps After Q1 Sales Double and AI Storage Outlook Tops Estimates

Silicon Motion Stock Jumps After Q1 Sales Double and AI Storage Outlook Tops Estimates

29 April 2026
Silicon Motion reported first-quarter revenue of $342.1 million, up 105% from a year earlier, and forecast second-quarter sales above Wall Street estimates. Shares rose $45.09 to $194.27 in New York trading. The company cited strong demand for embedded storage controllers and AI-related enterprise storage. CEO Wallace Kou said its MonTitan SSD controller platform will enter volume production this quarter.
Starbucks Stock Surges After Earnings Beat Makes Niccol’s Turnaround Look Real

Starbucks Stock Surges After Earnings Beat Makes Niccol’s Turnaround Look Real

29 April 2026
Starbucks raised its fiscal 2026 outlook after global comparable store sales rose 6.2% in the second quarter, beating analyst estimates. Shares jumped about 10% to $107.03. North American operating margin fell to 9.9% from 11.6% due to higher labor and product costs. The company now expects at least 5% comparable sales growth for the year.
Adaptive Biotechnologies (ADPT) stock swings after earnings as MRD guidance, insider sale draw scrutiny
Previous Story

Adaptive Biotechnologies (ADPT) stock swings after earnings as MRD guidance, insider sale draw scrutiny

Apple stock rises as memory-chip crunch revives iPhone price questions
Next Story

Apple stock rises as memory-chip crunch revives iPhone price questions

Go toTop